HB2199, titled the Restore Protections for Dialysis Patients Act, would amend the Medicare Secondary Payer Act provisions in the Social Security Act to strengthen protections for people with end stage renal disease (ESRD). The bill states that private health plans may not discriminate against individuals with ESRD or dialysis needs, and may not structure benefits in a way that treats dialysis less favorably than other covered medical services. It is aimed at preventing private coverage arrangements from shifting the cost of dialysis-related care onto Medicare.
The bill also clarifies that while health plans cannot single out dialysis for disfavored treatment, they are not required to include any particular dialysis provider or a minimum number of dialysis providers in their networks. It directs the Secretary of Health and Human Services to enforce the provision consistently with existing federal nonconformance rules. In effect, the bill seeks to preserve Medicare’s secondary payer protections while drawing a line between prohibited benefit discrimination and permissible network design choices.
Impact
If enacted, the bill would amend section 1862(b)(1)(C) of the Social Security Act, expanding and clarifying the statutory prohibition on private plans differentiating between ESRD patients and other enrollees. It would affect group health plans and other private insurance arrangements that cover dialysis services, limiting their ability to impose coverage restrictions that disproportionately burden ESRD patients. The measure would not require plans to contract with specific dialysis providers, but it would constrain benefit design and coverage limitations that could shift primary payment responsibility to Medicare.
Sentiment
The available context suggests generally supportive sentiment, with bipartisan sponsorship from members of both parties and no recorded committee opposition or votes in the provided materials. The bill’s title and stated purposes indicate a patient-protection focus, and its language is framed as a clarification of existing Medicare protections rather than a major policy expansion. No committee transcript is available, so the broader debate cannot be directly assessed from the provided record.
Contention
The main point of contention is likely the balance between protecting dialysis patients from discriminatory coverage and preserving private insurers’ flexibility to manage provider networks and benefits. The bill expressly says plans may not discriminate based on ESRD or dialysis needs, but also says they are not required to include any particular dialysis provider or number of providers in-network. That carveout suggests concern from insurers or plan sponsors about network mandates, while patient advocates would likely focus on ensuring that coverage limits do not effectively steer costs to Medicare or reduce access to dialysis care.